Ambrx Biopharma Cayman, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $673K, a 227% increase year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2022 was $1.87M, a 7.58% increase from 2021.
  • Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2021 was $1.74M, a 2.96% increase from 2020.
  • Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2020 was $1.69M, a 3.05% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $673K +$467K +227% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $731K +$134K +22.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q2 2022 $206K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $597K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.